Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Javier Coindreau
Cost-Effectiveness of Early Treatment With Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients With Established Rheumatoid Arthritis
Advances in Therapy
Medicine
Pharmacology
Clinical and Regulatory Perspectives on Biosimilar Therapies and Intended Copies of Biologics in Rheumatology
Rheumatology International
Rheumatology
Allergy
Immunology
Related publications
Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone
RMD Open
Rheumatology
Allergy
Immunology
Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
PLoS ONE
Multidisciplinary
Therapies for Active Rheumatoid Arthritis After Methotrexate Failure
Rheumatology: Current Research
Effectiveness of TNF Inhibitor Treatment With Various Methotrexate Doses in Patients With Rheumatoid Arthritis: Results From Clinical Practice
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients With Rheumatoid or Psoriatic Arthritis
PharmacoEconomics - Open
Health Policy
Pharmacology
